Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Medpace financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$329.8
2024-10-29
Market Capitalization
$10.2 B
2024-10-29
Revenue
$2.1 B
FY, 2024
CreditSafe Score
?
Score changed on Mar 27, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|
| Revenue | 1.1B | 1.5B | 1.9B | 2.1B |
| Cost of goods sold | 814.2M | 1.0B | 1.4B | 1.5B |
| Gross profit | 328.2M | 432.4M | 524.5M | 656.3M |
| Gross profit margin, % | 28.7% | 29.6% | 27.8% | 31.1% |
| General and administrative expense | 108.4M | 131.4M | 161.4M | 180.2M |
| Operating expense total | 129.5M | 153.7M | 187.7M | 209.4M |
| Depreciation and amortization | 21.1M | 22.3M | 26.3M | |
| EBIT | 198.6M | 278.7M | 336.8M | 446.9M |
| EBIT margin, % | 17.4% | 19.1% | 17.9% | 21.2% |
| Interest expense | 105.0K | 2.9M | 488.0K | 25.0M |
| Pre tax profit | 201.9M | 282.9M | 335.7M | 475.9M |
| Income tax expense | 20.0M | 37.5M | 52.9M | 71.5M |
| Net Income | 181.8M | 245.4M | 282.8M | 404.4M |
| EPS | 4.8 | 7.3 | 8.9 | 12.6 |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |